Pharmaco - Press Releases

Date	Title	Company
29-Jun-2021	Relief and APR Applied Pharma Research Sign and Close Definitive Agreement for Relief to Acquire All Outstanding Shares of APR	RELIEF THERAPEUTICS Holdings AG
29-Jun-2021	Formycon and Bioeq announce submission of the marketing authorization application for FYB201, a biosimilar candidate to Lucentis(R)1 (ranibizumab) to the European Medicines Agency (EMA)	Formycon AG
28-Jun-2021	Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Financial Guidance	Vivoryon Therapeutics N.V.
28-Jun-2021	Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China	Vivoryon Therapeutics N.V.
28-Jun-2021	Vivoryon Therapeutics N.V.: Ordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V.	Vivoryon Therapeutics N.V.
28-Jun-2021	Teva Pharmaceutical Industries Ltd. becomes strategic partner for the commercialization of FYB201, Formycon's biosimilar candidate to Lucentis(R)1 (ranibizumab) in Europe, Canada, Israel and New Zealand	Formycon AG
28-Jun-2021	Formycon announces conclusion of exclusive commercialization agreement between Bioeq AG and Teva Pharmaceutical Industries Ltd. for FYB201 in Europe, Canada, Israel and New Zealand	Formycon AG
28-Jun-2021	2021 Young Scientist Award winners announced	Boehringer Ingelheim
28-Jun-2021	Polyphor provides update on the Phase III FORTRESS study of balixafortide in patients with advanced HER2 negative breast cancer	Polyphor AG
26-Jun-2021	Medical Robotics Market Research Report With Opportunities And Strategies To Boost Growth- COVID-19 Impact And Recovery during 2021-2028 – Agilent Technologies, Mako Surgical Corp, Mazor Robotics, Abbot Diagnostics	Lexis Business Insights
26-Jun-2021	Global Prostate Cancer Treatment Market to receive overwhelming hike in Revenues by 2021 – 2028 Top Key Players Like Bayer AG, Indevus Pharmaceuticals Inc., BioMark Diagnostics Inc., Astellas Pharma Inc.	Lexis Business Insights
26-Jun-2021	HIV Market Research Provides In-depth Analysis of the Industry with Current Trends and Future Scope\|Mylan Pharmaceuticals, ViiV Healthcare, Gilead Sciences, Genentech	Lexis Business Insights
25-Jun-2021	Biomarker Development and Growing Demand for Personalized Medicine Will Drive the Growth - Metabolomics Market worth $4.1 billion	MarketsandMarkets Research Private Ltd.
25-Jun-2021	MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma	MorphoSys AG
25-Jun-2021	Lab Informatics Market Growth Strategies & Future Opportunities	MarketsandMarkets Research Private Ltd.
25-Jun-2021	PharmaSGP successfully holds first AGM after IPO	PharmaSGP Holding SE
25-Jun-2021	Medigene AG: Medigene reports on Annual General Meeting 2021	Medigene AG
25-Jun-2021	Oxurion NV to Focus Resources on Clinical Assets THR-687 and THR-149 Timeline Guidance for Both Programs Confirmed	Oxurion NV
25-Jun-2021	Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expression	Sanofi
25-Jun-2021	Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinoma	Sanofi